Literature DB >> 8639508

Human DNA polymerase epsilon: enzymologic mechanism and gap-filling synthesis.

D J Mozzherin1, P A Fisher.   

Abstract

DNA polymerase epsilon (pol epsilon) was purified to apparent homogeneity from human placentas. The purified enzyme contains a single polypeptide of approximately 170 kDa (apparent mass) and has both DNA polymerase and 3'-5'-exonuclease activities. Competitive inhibition studies indicate that like DNA polymerases alpha and delta (pol alpha and pol delta, respectively), free pol epsilon binds single-stranded but not double-stranded DNA. This conclusion was confirmed by sedimentation binding analysis. Also like pol alpha and pol beta, pol epsilon exhibits induced dNTP inhibition in the presence of template annealed to complementary primer containing a 2',3'-H (dideoxy)-terminus. Together, these data suggest that pol epsilon follows an ordered sequential ter-reactant mechanism of substrate recognition and binding; it binds template first followed by annealed primer and then template-specified dNTP. Enzymologic studies suggest that in contrast to both pol alpha and pol delta, pol epsilon functions more efficiently as gap size decreases. This observation is consistent with a specific role for pol epsilon in gap-filling in vivo. Gap-filling is essential for both replication and repair.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639508     DOI: 10.1021/bi952142p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

Review 1.  DNA polymerase epsilon: a polymerase of unusual size (and complexity).

Authors:  Zachary F Pursell; Thomas A Kunkel
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2008

2.  The high fidelity and unique error signature of human DNA polymerase epsilon.

Authors:  Dagmara A Korona; Kimberly G Lecompte; Zachary F Pursell
Journal:  Nucleic Acids Res       Date:  2010-10-29       Impact factor: 16.971

3.  Endogenous human MDM2-C is highly expressed in human cancers and functions as a p53-independent growth activator.

Authors:  Danielle R Okoro; Nicoleta Arva; Chong Gao; Alla Polotskaia; Cindy Puente; Melissa Rosso; Jill Bargonetti
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

4.  Validating the concept of mutational signatures with isogenic cell models.

Authors:  Xueqing Zou; Michel Owusu; Rebecca Harris; Stephen P Jackson; Joanna I Loizou; Serena Nik-Zainal
Journal:  Nat Commun       Date:  2018-05-01       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.